Social Network Interventions

Landmark Center at 401 Park Drive, 5th floor East, Boston, MA 02215

Speaker: Nicholas A. Christakis, MD, PhD, MPH, at Yale University

Date: December 16, 2019 at 4:00PM - 5:30PM

Human beings choose their friends, and often their neighbors and co-workers, and they inherit their relatives; and each of the people to whom we are connected also does the same, such that, in the end, we humans assemble ourselves into face-to-face social networks. Why do we do this? How has natural selection shaped us in this regard? What role do our genes play in the topology of our social ties? And how might a deep understanding of human social network structure and function be used to intervene in the world to make it better?

Nicholas A. Christakis, MD, PhD, MPH, is a social scientist and physician at Yale University who conducts research in the fields of network science, biosocial science, and behavior genetics. His current work focuses on how human biology and health affect, and are affected by, social interactions and social networks. He directs the Human Nature Lab and is the Co-Director of the Yale Institute for Network Science. He is the Sterling Professor of Social and Natural Science, appointed in the Departments of Sociology; Medicine; Ecology and Evolutionary Biology; Biomedical Engineering; and the School of Management.

Dr. Christakis received his BS from Yale in 1984, his MD from Harvard Medical School and his MPH from the Harvard School of Public Health in 1989, and his PhD from the University of Pennsylvania in 1995. He was elected to the National Academy of Medicine in 2006; the American Association for the Advancement of Science in 2010; and the American Academy of Arts and Sciences in 2017.

One body of work in his lab focuses on how health and health behavior in one person can influence analogous outcomes in a person’s social network. This work involves the application of statistical and mathematical models to understand the dynamics of diverse phenomena in longitudinally evolving networks. A related body of work uses experiments to examine the spread of altruism, emotions, and health behaviors along network connections online and offline, including with large-scale field trials in the developing world directed at improving public health (e.g., in Honduras and India). His lab has also examined the genetic and evolutionary determinants of social network structure, showing that social interactions have shaped our genome, with related projects that have mapped networks of populations in Tanzania and Sudan who live as all humans did 10,000 years ago. His most recent work has used artificial intelligence (AI) agents (“bots") to affect social processes online.

Dr. Christakis is the author of over 200 articles and several books. His influential book, Connected: The Surprising Power of Our Social Networks and How They Shape Our Lives, documented how social networks affect our lives and was translated into twenty foreign languages. His most recent book, Blueprint: The Evolutionary Origins of a Good Society, was published in March 2019 and is slated to appear in German, Chinese, Dutch, and Greek, and other languages.

In 2009, Dr. Christakis was named by Time magazine to their annual list of the 100 most influential people in the world. In 2009 and in 2010, he was listed by Foreign Policy magazine in their annual list of Top 100 Global Thinkers.


Hopper RK, Abman SH, Elia EG, Avitabile CM, Yung D, Mullen MP, Austin ED, Bates A, Handler SS, Feinstein JA, Ivy DD, Kinsella JP, Mandl KD, Raj JU, Sleeper LA, . Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry. The Journal of pediatrics 2022.

Wang X, Zhang HG, Xiong X, Hong C, Weber GM, Brat GA, Bonzel CL, Luo Y, Duan R, Palmer NP, Hutch MR, Gutiérrez-Sacristán A, Bellazzi R, Chiovato L, Cho K, Dagliati A, Estiri H, García-Barrio N, Griffier R, Hanauer DA, Ho YL, Holmes JH, Keller MS, Klann MEng JG, L'Yi S, Lozano-Zahonero S, Maidlow SE, Makoudjou A, Malovini A, Moal B, Moore JH, Morris M, Mowery DL, Murphy SN, Neuraz A, Yuan Ngiam K, Omenn GS, Patel LP, Pedrera-Jiménez M, Prunotto A, Jebathilagam Samayamuthu M, Sanz Vidorreta FJ, Schriver ER, Schubert P, Serrano-Balazote P, South AM, Tan ALM, Tan BWL, Tibollo V, Tippmann P, Visweswaran S, Xia Z, Yuan W, Zöller D, Kohane IS, Avillach P, Guo Z, Cai T, . SurvMaximin: Robust federated approach to transporting survival risk prediction models. Journal of biomedical informatics 2022.

Torous J, Stern AD, Bourgeois FT. Regulatory considerations to keep pace with innovation in digital health products. NPJ digital medicine 2022.

Levy S, Wisk LE, Minegishi M, Ertman B, Lunstead J, Brogna M, Weitzman ER. Association of Screening and Brief Intervention With Substance Use in Massachusetts Middle and High Schools. JAMA network open 2022.

Nielsen M, Presti M, Sztupinszki Z, Jensen AWP, Draghi A, Chamberlain CA, Schina A, Yde CW, Wojcik J, Szallasi Z, Crowther MD, Svane IM, Donia M. Co-existing alterations of MHC class I antigen presentation and IFNγ signaling mediate acquired resistance of melanoma to post-PD-1 immunotherapy. Cancer immunology research 2022.